NUP153 - C-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-NUP153 - C-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityNUP153 - C-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, guinea pig, horse, human, mouse, porcine, rabbit, rat
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against NUP153. It was validated on Western BlotTarget Description: Nuclear pore complexes are extremely elaborate structures that mediate the regulated movement of macromolecules between the nucleus and cytoplasm. These complexes are composed of at least 100 different polypeptide subunits, many of which belong to the nucleoporin family. Nucleoporins are pore complex-specific glycoproteins characterized by cytoplasmically oriented O-linked N-acetylglucosamine residues and numerous repeats of the pentapeptide sequence XFXFG. The protein encoded by this gene has three distinct domains: a N-terminal region within which a pore targeting domain has been identified, a central region containing multiple
Immunogenn/a
Other Names[nuclear pore complex protein Nup153 isoform 2; Nuclear pore complex protein Nup153; nuclear pore complex protein Nup153; nucleoporin 153; 153 kDa nucleoporin; Nucleoporin Nup153]
Gene, Accession #[NUP153], Gene ID: 9972, NCBI: NP_005115, UniProt: P49790
Catalog #MBS3215234
Price$335
Order / More InfoNUP153 - C-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.